This announcement is a separate document:
灵康药业：关于“灵康转债“2022年跟踪评级结果的公告
Lingkang Pharmaceutical: Announcement on the tracking rating results of “Lingkang Convertible Bonds” in 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated